A three-tiered approach to address barriers to COVID-19 vaccine delivery in the Black community

Deaths attributable to COVID-19 continue to increase disproportionately in Black and Brown communities.1 Specifically, Black people represent 14·8% of all COVID-19 mortalities in the USA, which is greater than the proportion of Black individuals in the US population (13·4%). This disparate outcome is heavily attributed to the inter-relationship between structural racism and the social determinants of health inequities.1,2 The availability of COVID-19 vaccines are positioned to change these inequalities; however, decades of institutional distrust and inadequate access to health care, and ultimately, the absence of transparency in vaccine allocation to heavily disparaged areas, leave Black communities at a disadvantage.